7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Cardiff Oncology, Inc
(NASDAQ:CRDF) 

CRDF stock logo

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has c...

Founded: 1999
Full Time Employees: 12
CEO: Mark Erlander  
Sector: Healthcare
Industry: Biotechnology
BiotechnologyOncology
Share this website to your friends
Cardiff Oncology Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0257.57515.14772.711,030.281,287.851,545.421,802.99
Cardiff Oncology Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0155.82311.64467.47623.29779.11934.931,090.76
Cardiff Oncology Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.78-0.67-0.56-0.45-0.33-0.22-0.110
Cardiff Oncology Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.8-0.68-0.57-0.46-0.34-0.23-0.110
Cardiff Oncology Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.40.81.211.612.012.412.82
Cardiff Oncology P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 076.38152.76229.14305.52381.9458.28534.66
Cardiff Oncology (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.42-5.51-4.59-3.67-2.75-1.84-0.920
Cardiff Oncology P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.531.071.62.142.673.213.74
No extra charts and metrics for this ticker.